[Effect of moxonidine on parameters of lipid metabolism in patients with metabolic syndrome.].
To compare effects of moxonidine and lisinopril on parameters of lipid metabolism in patients with metabolic syndrome. Moxonidine (0.2-04 mg/day) and lisinopril (10-20 mg/day) were given to 25 and 24 patients, respectively. Blood pressure, heart rate, parameters of lipid profile and fasting blood glucose were measured before and after 12 weeks of treatment. Antihypertensive efficacy of 2 drugs was similar. No changes of lipid profile occurred in lisinopril treated patients while significant elevation of high density lipoprotein cholesterol and tendency to lowering of triglyceride level were observed in moxonidine group. Therapy with moxonidine was associated with favorable changes of lipid profile.